|
1
|
Shahrabi S, Rezaeeyan H, Ahmadzadeh A,
Shahjahani M and Saki N: Bone marrow blood vessels: Normal and
neoplastic niche. Oncol Rev. 10:3062016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ramasamy SK: Structure and Functions of
Blood Vessels and Vascular Niches in Bone. Stem Cells Int.
2017:50469532017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Manabe A, Coustan-Smith E, Behm FG,
Raimondi SC and Campana D: Bone marrow-derived stromal cells
prevent apoptotic cell death in B-lineage acute lymphoblastic
leukemia. Blood. 79:2370–2377. 1992.PubMed/NCBI
|
|
4
|
Manabe A, Murti KG, Coustan-Smith E,
Kumagai M, Behm FG, Raimondi SC and Campana D: Adhesion-dependent
survival of normal and leukemic human B lymphoblasts on bone marrow
stromal cells. Blood. 83:758–766. 1994.PubMed/NCBI
|
|
5
|
Dominici M, Le Blanc K, Mueller I,
Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A,
Prockop DJ and Horwitz E: Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy. 8:315–317. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Glodek AM, Le Y, Dykxhoorn DM, Park SY,
Mostoslavsky G, Mulligan R, Lieberman J, Beggs HE, Honczarenko M
and Silberstein LE: Focal adhesion kinase is required for
CXCL12-induced chemotactic and pro-adhesive responses in
hematopoietic precursor cells. Leukemia. 21:1723–1732. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Acharya M, Edkins AL, Ozanne BW and
Cushley W: SDF-1 and PDGF enhance alphavbeta5-mediated ERK
activation and adhesion-independent growth of human pre-B cell
lines. Leukemia. 23:1807–1817. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Arnaud MP, Vallée A, Robert G, Bonneau J,
Leroy C, Varin-Blank N, Rio AG, Troadec MB, Galibert MD and
Gandemer V: CD9, a key actor in the dissemination of lymphoblastic
leukemia, modulating CXCR4-mediated migration via RAC1 signaling.
Blood. 126:1802–1812. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Shen N, Ffrench P, Guyotat D, Ffrench M,
Fiere D, Bryon PA and Dechavanne M: Expression of adhesion
molecules in endothelial cells during allogeneic bone marrow
transplantation. Eur J Haematol. 52:296–301. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mihara K, Imai C, Coustan-Smith E, Dome
JS, Dominici M, Vanin E and Campana D: Development and functional
characterization of human bone marrow mesenchymal cells
immortalized by enforced expression of telomerase. Br J Haematol.
120:846–849. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Roecklein BA and Torok-Storb B:
Functionally distinct human marrow stromal cell lines immortalized
by transduction with the human papilloma virus E6/E7 genes. Blood.
85:997–1005. 1995.PubMed/NCBI
|
|
12
|
Greco WR, Bravo G and Parsons JC: The
search for synergy: A critical review from a response surface
perspective. Pharmacol Rev. 47:331–385. 1995.PubMed/NCBI
|
|
13
|
To LB, Levesque JP and Herbert KE: How I
treat patients who mobilize hematopoietic stem cells poorly. Blood.
118:4530–4540. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fricker SP: Physiology and pharmacology of
plerixafor. Transfus Med Hemother. 40:237–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sánchez-Martín L, Sánchez-Mateos P and
Cabañas C: CXCR7 impact on CXCL12 biology and disease. Trends Mol
Med. 19:12–22. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Asri A, Sabour J, Atashi A and Soleimani
M: Homing in hematopoietic stem cells: Focus on regulatory role of
CXCR7 on SDF1a/CXCR4 axis. EXCLI J. 15:134–143. 2016.PubMed/NCBI
|
|
17
|
Sison EA, Rau RE, McIntyre E, Li L, Small
D and Brown P: MLL-rearranged acute lymphoblastic leukaemia stem
cell interactions with bone marrow stroma promote survival and
therapeutic resistance that can be overcome with CXCR4 antagonism.
Br J Haematol. 160:785–797. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nishii K, Katayama N, Miwa H, Shikami M,
Masuya M, Shiku H and Kita K: Survival of human leukaemic B-cell
precursors is supported by stromal cells and cytokines: Association
with the expression of bcl-2 protein. Br J Haematol. 105:701–710.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Juarez J, Bradstock KF, Gottlieb DJ and
Bendall LJ: Effects of inhibitors of the chemokine receptor CXCR4
on acute lymphoblastic leukemia cells in vitro. Leukemia.
17:1294–1300. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Welschinger R, Liedtke F, Basnett J, Dela
Pena A, Juarez JG, Bradstock KF and Bendall LJ: Plerixafor
(AMD3100) induces prolonged mobilization of acute lymphoblastic
leukemia cells and increases the proportion of cycling cells in the
blood in mice. Exp Hematol. 41:293–302, e291. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sison EA, Magoon D, Li L, Annesley CE, Rau
RE, Small D and Brown P: Plerixafor as a chemosensitizing agent in
pediatric acute lymphoblastic leukemia: Efficacy and potential
mechanisms of resistance to CXCR4 inhibition. Oncotarget.
5:8947–8958. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sison EA, Magoon D, Li L, Annesley CE,
Romagnoli B, Douglas GJ, Tuffin G, Zimmermann J and Brown P:
POL5551, a novel and potent CXCR4 antagonist, enhances sensitivity
to chemotherapy in pediatric ALL. Oncotarget. 6:30902–30918. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Randhawa S, Cho BS, Ghosh D, Sivina M,
Koehrer S, Müschen M, Peled A, Davis RE, Konopleva M and Burger JA:
Effects of pharmacological and genetic disruption of CXCR4
chemokine receptor function in B-cell acute lymphoblastic
leukaemia. Br J Haematol. 174:425–436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cooper TM, Sison EAR, Baker SD, Li L,
Ahmed A, Trippett T, Gore L, Macy ME, Narendran A, August K, et al:
A phase 1 study of the CXCR4 antagonist plerixafor in combination
with high-dose cytarabine and etoposide in children with relapsed
or refractory acute leukemias or myelodysplastic syndrome: A
Pediatric Oncology Experimental Therapeutics Investigators'
Consortium study (POE 10-03). Pediatr Blood Cancer.
doi.10.1002/pbc.26414.
|
|
25
|
Anthony BA and Link DC: Regulation of
hematopoietic stem cells by bone marrow stromal cells. Trends
Immunol. 35:32–37. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Karpova D and Bonig H: Concise Review:
CXCR4/CXCL12 signaling in immature hematopoiesis-lessons from
pharmacological and genetic models. Stem Cells. 33:2391–2399. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gomes AC and Gomes MS: Hematopoietic
niches, erythropoiesis and anemia of chronic infection. Exp
Hematol. 44:85–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Rustom A, Saffrich R, Markovic I, Walther
P and Gerdes HH: Nanotubular highways for intercellular organelle
transport. Science. 303:1007–1010. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Spees JL, Olson SD, Whitney MJ and Prockop
DJ: Mitochondrial transfer between cells can rescue aerobic
respiration. Proc Natl Acad Sci USA. 103:1283–1288. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X and Gerdes HH: Transfer of
mitochondria via tunneling nanotubes rescues apoptotic PC12 cells.
Cell Death Differ. 22:1181–1191. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lou E, Fujisawa S, Morozov A, Barlas A,
Romin Y, Dogan Y, Gholami S, Moreira AL, Manova-Todorova K and
Moore MA: Tunneling nanotubes provide a unique conduit for
intercellular transfer of cellular contents in human malignant
pleural mesothelioma. PLoS One. 7:e330932012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pasquier J, Guerrouahen BS, Al Thawadi H,
Ghiabi P, Maleki M, Abu-Kaoud N, Jacob A, Mirshahi M, Galas L,
Rafii S, et al: Preferential transfer of mitochondria from
endothelial to cancer cells through tunneling nanotubes modulates
chemoresistance. J Transl Med. 11:942013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moschoi R, Imbert V, Nebout M, Chiche J,
Mary D, Prebet T, Saland E, Castellano R, Pouyet L, Collette Y, et
al: Protective mitochondrial transfer from bone marrow stromal
cells to acute myeloid leukemic cells during chemotherapy. Blood.
128:253–264. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marlein CR, Zaitseva L, Piddock RE,
Robinson SD, Edwards DR, Shafat MS, Zhou Z, Lawes M, Bowles KM and
Rushworth SA: NADPH oxidase-2 derived superoxide drives
mitochondrial transfer from bone marrow stromal cells to leukemic
blasts. Blood. 130:1649–1660. 2017.PubMed/NCBI
|
